chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Approximately 9 hours after the vaccination, I began to shiver uncontrollably. This (along with other side effects, is not uncommon, and I also experienced headache widespread muscle soreness and some nausea). But the shivering was very dramatic, and unlike anything I'd experienced before. I could not stop it or relax for about 4 hours duration.  I was finally able to relax and stop the shivering about 2 AM. I'm only reporting this as a way to document one of Shingrix's rather more extreme side effects.
Petechiae - a few on my abdomen, one small dot on my upper leg, one on my throat and many small dots across  both biceps. I have young children whom I lift - that may have caused them to show on my arms.  I recognize these as the same kinds of marks that appeared when I had dengue hemorrhagic fever in 2018.
I have photos.  It's now a week + hours since dose 1 of Moderna Vaccine. On day 2:  felt like a bad bee sting in vaccination site Days 3-8: Excessive Swelling, extreme itchiness and redness in and around vaccine site.  On Day 4- two pea-sized purple  subcutaneous circles appeared on the lower under-side of the vaccinated arm. On Day 5: Two more pea-sized purple  subcutaneous  appeared on the lower under-side of the vaccinated arm.  As of today, I now have 4. I went to my dermatologist today (Feb 19th) who thinks the condition may be Senile Purura.  He also prescribed Lidocaine for the continuous and disruptive itchiness. I have to contact the dermatologist after the weeke I have photos.
fever/febrile szs 6hrs p/vax given on 22DEC95
Information has been received from a physician concerning a 10 year old female who on 07-DEC-2000 and 19-AUG-2004 was vaccinated with the first and second doses of MMR II (lot # not reported) respectively. On 25-NOV-2009 the patient was diagnosed with mumps. The patient was afebrile and had a right parotitis. The first bloodwork on 25-NOV-2009 revealed serum IgM (immunoglobulin M) <1:10, serum IgG (immunoglobulin G) 1.1 and serum amylase 39. The outcome of the mumps was unknown. Additional information has been requested.
By 5:00 pm (day of the shot) had a large red lump the size of a fist. Very sore and warm to the touch.
1/25 rcv'd vax at ER post laceration. 1/31 redness, swelling, tenderness to R deltoid. Treated. Returned again w/ inc cellulitis to R shoulder. Admitted. Sx consistent w/ DT being given SQ. Documented  5/8" needle used for vax.
Information has been reported in a CDC slide titled as "Safety of PNEUMOVAX 23 in the Vaccine Adverse Reporting System (VAERS)". This spontaneous prospective pregnancy report as received from a registered nurse (RN) in Centers for Disease Control and Prevention (CDC) concerning a female patient of unknown age, 4 of the six patients who experienced cellulitis. On an unknown date, the patient became pregnant. The last menstrual period (LMP) and estimated date of delivery (EDD) was not known. On an unknown date the patient was administered with a dose of PNEUMOVAX 23 (lot#, dose and route were unspecified) during pregnancy. On an unknown date the patient experienced cellulitis. The outcome of cellulitis was unknown. The pregnancy outcome was unknown. This is one of the 18 reports (PNEUMOVAX 23 administered during pregnancy) that received from the same source. Additional information has been requested.
2 weeks after date of 1st moderna shot my injection site has turned red and there is a knot there.
I suffered two heart attacks. First heart attack was on the 6th day after the vaccine, second heart attack was on the 9th day of vaccine. Both heart attacks woke me up from sleep. I went to the emergency room and was hospitalized each time. I suffered chest pain prior to each heart attack but have never suffered chest pain before. I am continuing to suffer from periods of chest pain at rest.
2 days p/vax mom of child noted redness & warmth @ site of inj;pt seen in office 4 days p/vax;dx of allergic rxn w/ 6cm x 4.5cm area of erythema & swelling, warmth beneath site of DTAP;tx keflex for cellulitis;DPH;
Lost all body fluid function, chills, fever, body ache, headache, diarrhea, vomiting, numbness in leg and arm has not went away still.
very sore throat today; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (very sore throat today) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jun-2021, the patient experienced OROPHARYNGEAL PAIN (very sore throat today). At the time of the report, OROPHARYNGEAL PAIN (very sore throat today) outcome was unknown.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
My period cramps were severe and I was bleeding clumps of blood that were thick like boogers rather than blood that was liquid in texture. I normally do not have bad period cramps and I don't bleed clumps of blood when I?m  on my period.
This spontaneous report was received from a healthcare worker referring to a multiple unspecified patients of unknown ages. The patients' medical history and concurrent conditions were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of ZOSTAVAX, (lot # N016185, expiry date 31-JUL-2018).  Other suspect therapies included sterile diluent (manufacturer unknown). It was reported that the vaccines were improperly stored with a temperature excursions between -14°c to -10°c during 2.5 hours. It was reported because a data logger. The sterile diluent (manufacturer unknown) used to reconstituted all vaccines were properly stored. No adverse effects were reported. The outcome of incorrect product storage and no adverse event was unknown. This is one of two reports from the same reporter source, (linked to MARRS # 1707USA011252). Additional information has been requested. Lot # N016185 is a valid lot # for ZOSTAVAX.; Sender's Comments:  US-009507513-1707USA011252:
Twitching right lower eyelid 3 hours after injection. Spread to right area around mouth within 3 days. Muscle spasms in legs and arms also. Twitching and spasms have been ongoing for 28 days
Immediately after injection patient developed a hard bump at injection site. Approximately quarter sized. She showed no other symptoms.
48 patients received an expired vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (48 patients received an expired vaccine) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (48 patients received an expired vaccine). On 11-Nov-2021, EXPIRED PRODUCT ADMINISTERED (48 patients received an expired vaccine) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications reported.  No treatment information was provided.
Site: Pain at Injection Site-Mild, Systemic: Body Aches Generalized-Medium, Systemic: Vomiting-Medium, Systemic: Weakness-Medium, Additional Details: AER# from Pfizer / BioNtech Covid Vaccine follow up Questionnaire from Pfizer
Within minutes of second Pfizer dose, while still sitting in observation chair, patient started with uncontrollable shaking of all 4 limbs.  She was escorted to the ER of the hospital where she works as an RN and where she received the vaccine.  At the time I evaluated her on  7/15/21 she reported continuing to have attacks of shaking about every 2 days, lasting several hours.
Whole body muscle weakness; low-grade fever; headache; fatigue. When to bed and slept--drank fluids.
Cuyamaca team 2 was notified of a potential adverse reactions of a patient whom just received the second dose of vaccine. The patient was found in her car with husband onscene appearing to be in minor distress. Per the patient she has a history of anxiety and feels that she is having a anxious epsiode. Patient admits to having a similar effect post first dose. Patient admitted to " fluttering in the chest" as well as numbness in the fingers, patient was slightly tachypnic upon inital contact. Patient was advised of calming measures and symptoms began to subside. A full 911 response was started and performed a AMA, Heartland CAD # 2021-00012209. "PFIZER COVID 19 VACCINE EUA"
Rcd 2012-13 Influenza vaccine on 10/2/12. Felt pain to elbow within 30 minutes of IZ. Slowly feeling N/general malaise. Came to Occ Health 10/4/12. Has 10cm x 3cm area of erythema/induration & itch.
Information has been received from a registered nurse concerning a female who on 8/19/05 was vaccinated with a first dose of pneumococcal 23v polysaccharide vaccine. On 8/19/05, the patient developed redness, swelling, and induration that extended beyond the shoulder into the chest region. It was noted that the patient could not move her arm. It was also noted that the reaction required an additional office visit for the patient. Unspecified medical attention was sought. The patient's outcome was unknown. No product quality complaint was involved. Redness, swelling and induration were considered to be disabling. Additional information has been requested.
He had mostly low-grade fever, fussiness, and URI symptoms develop, with purulent nasal discharge. The intermittent fevers continued for several days while traveling. His temperature peaked at 102.1F on 10/29/13. Seen in urgent care, had bilateral otitis media. Treated with high-dose amoxicillin with good resolution of his symptoms.
Information has been received from a healthcare worker concerning an unspecified number of patients of unknown age and gender. No concurrent or historical conditions were reported. Since unknown dates from 07-APR-2015, the patients were vaccinated with (Oka-Merck) PROQUAD (route and dose not reported, Lot# L002419 and expiration date 23-JUL-2016), which were exposed to temperatures outside of the recommended range. No adverse effect had been reported. This is one of several reports received from the same reporter. Additional information has been requested.
1:08pm client c/o feeling dizzy and thirsty.  Patient was offered water.  1:15pm Patient found on floor.  Patient was monitored and EMS called.   162/110, HR 88. EMS arrived, patient refused transportation, was accompanied home by husband.  Patient was advised to call 911 or contact medical doctor if still experiencing symptoms.  Understanding verbalized.  13:40 Patient left site, accompanied by husband.
Approx 12 hrs after imm she developed fever/cough -> 104 -> continue x 4 days, has decreased energy, no achy, URI & sore throat now with persistent cough.
Two hours after administering the flu vaccine, patient complained of headache. (throbbing). BP 140/90 mmHg at 3pm. BP 120/88 after 30 mins.
She felt sharp chest pain within 10-15 minutes after receiving the vaccines, came back to Health to report.  VS were normal and she started feeling dizzy.  Transported to the ED for evaulation.
A report has been received from a Health Professional concerning a 10 year old, Female subject, who had been receiving FLUMIST. FLUMIST started on an unknown date. The reporter stated that when FLUMIST was administered, the patient pulled back and FLUMIST sprayed in the patient's left eye on 02-Oct-2013. The outcome of the event of WHEN ADMINISTERING FLUMIST THE PATIENT PULLED BACK AND IT SPRAYED IN THE LEFT EYE is unknown. The report was considered to be non-serious.
Extreme deep pain in hips and shoulders lasting approx. 6 hours - worst pain I've ever felt including broken bones Fever, body aches, flu-like symptoms were not unexpected - lasted 24 hours
As part of our annual Physical exam, we were routed to a room where the Shingles vaccine was being administered. We were not given documentation outlining side-effects, especially for immunocompromised patients. My wife was a given the vaccine and within a week or so developed a rash and twitching of her face and pain in her right eye. She had been immunocompromised by chemotherapy (5FU). These problems have increased with time and clonazepam no longer controls it. She is in daily agony. Is there no antiviral that can shut down chicken pox?
Started at midnight 10/13/2013, redness at injection site, warmth, fever 98-102 degrees, headache. Patient taking Tylenol for fever and will take Benadryl for warmth and redness and apply cold compresses.
Patient stated that she has been itching and has had a rash since she received the vaccine. Patient stated that she is constantly itching. patient stated that she can not sleep because she is constantly itching.  Patient stated that administrator did not provide a LOT number for the second vaccine.
Fatigue; body ache; chills; This is a spontaneous report from a non-contactable consumer. A 43-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 13Apr2021 at 09:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 13Apr2021 at 17:00, the patient experienced fatigue, body aches and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events fatigue, body ache and chills were recovering at the time of this report.  No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
On 8/31/2011 client woke up in the AM feeling warm, chills, headache and dizzy. Client went to school where she again felt dizzy, chills and headache. client called into county IZ clinic at 1:20 pm on 8/31/2011, when she discribed her morning symptoms and that she still was feeling dizzy and with headache. Client's temp unknown per no temp taken. Advise to take temp and Tylenol for pain. Advise to seek medical attention at any point if symptoms don't subside or worsen.
Information has been received from a nurse concerning four patients who on unspecified dates was vaccinated with a dose of VARIVAX (Merck) (LOT# not reported). On unreported dates, after vaccination, the patients experienced local injection site reactions. No further information was available at the time of this report. Follow-up information has been received from a nurse concerning a 4 year old male who in the week or so of 24-JUL-2009 was vaccinated with a dose of VARIVAX (Merck). "During the week or so of 24-JUL-2009", the patient experienced injection site reactions. He had recovered at the time of this report. Follow-up information has been received from a nurse concerning the patient who on 30-JUL-2009 was vaccinated with his second dose of VARIVAX (Merck) (SC, lot # "0549Y"). Suspect vaccines included the second SQ dose of MMR II (MSD) (lot # 653749/0427F), the fourth IM dose of IPOL (lot # B6475), and fifth IM dose of DAPTACEL (lot #C3141AA). On 31-JUL-2009 in the afternoon, the patient's left upper arm was sore and swollen. His body temperature was 101 F. The patient was treated with BENADRYL (dose and duration not reported), TYLENOL (dose and duration not reported) and ice. It was reported that the patient also experienced edema to the elbow (which elbow was not specified), the patient received the IPOL and DAPTACEL in this arm. The patient visited the doctor for medical attention. At the time of this report, the patient was recovered. This is one of several reports from the same source. Additional information is not expected.
Pt recvd vax 8SEP92 w/vax; following day seen by MD for inject site react @ DTP site; erythema 6 1/2 x 8cm in size; treated w/DPH;
Information has been received from a consumer concerning his partner, a 67 year old male patient with medical history unspecified who in approximately 2006 was vaccinated with ZOSTER vaccine (Lot# was not provided). On an unspecified date, the patient experienced shingles. The outcome of shingles was not reported. This is one of several reports received from the same source. Additional information has been requested.
Swelling, redness, itching, inflammed from right shoulder down the right elbow and tender to touch. Onset of reaction was approx. 7 hours, post injection and progressed over the next 36 hours.
chills; goose bumps; feeling very cold; left arm injection site swelling; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 62 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 25Mar2021 09:00 (Lot number: ER8732, Expiration Date: 31Jul2021) at the age of 62 years as dose 1,single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: CHILLS (non-serious) with onset 25Mar2021, outcome "recovered" (26Mar2021), described as "chills"; PILOERECTION (non-serious) with onset 25Mar2021, outcome "recovered" (26Mar2021), described as "goosebumps"; FEELING COLD (non-serious) with onset 25Mar2021, outcome "recovered" (26Mar2021), described as "feeling very cold"; VACCINATION SITE SWELLING (non-serious) with onset 25Mar2021, outcome "recovered", described as "left arm injection site swelling". Therapeutic measures were taken as a result of chills, piloerection, feeling cold, vaccination site swelling.  Additional information: This report was not related to a study or programme. No, additional vaccines administered on same date of the Pfizer suspect. Prior vaccinations within 4 weeks were none. First Pfizer BioNTech COVID-19 Vaccine at about 9:00AM, and that entire evening, and throughout the night, she had chills, and goose bumps. She clarified she drove 50 miles to get her Pfizer BioNTech COVID-19 Vaccine. She said that evening, she was up the entire night with goose bumps, and feeling very cold. She did a lot of self-massage with heat therapy, drank tons of water, and had a professional massage.  No follow-up attempts are needed. No further information is expected.
Menstrual cycle began 4 days early, was heavier and lasted longer.  No treatment necessary.  Normally very regular to the day. This has never happened before.
Patient came to the health department with a prescription from her physician requesting Pneumonia, HIBA, and MENEMUNE. Nurse made and error by not mixing in diluent for HIBA. Inventory person noticed extra diluent in the refrigerator the next morning. Inventory person notified the nurse. Nurse contacted patient with information about medication error. Patient will return to the health department to receive the correct HIBA vaccine. Products Used. Pneumonia. PNEUMOVAX 23. Pneumococcal Polyvalent Vaccine. 0.5ml. Merck HIBA. ACTHIB. Haemophilus b Conjugate Vaccine. 0.5ml. Sanofi Pasteur MENEMUNE 0.5 cc. Patient denies any adverse reaction. Patient has an appointment X/XX/2012 with physician for follow up. Patient states she will notify her physician and will come to the health department as soon as she is able for vaccine. Outcome: Patient will return to the health department to receive the correct HIBA vaccine. Patient denies any adverse reaction. Patient has an appointment X/XX/2012 with physician for follow up. Patient states she will notify her physician and will come to the health department as soon as she is able for vaccine.
Pt turned white and nearly passed out immediately after injection.  The school called her parent and they picked her up.  No other reports were made by the parent
Immediate musuclar pain down entire left arm radiating to the shoulder and the neck, continuing 3 days later. Low grade fever upon awakening the next morning.
Itchy, red, slightly swollen area on upper left arm at injection site about 8 days after injection.
sore throat; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat). At the time of the report, OROPHARYNGEAL PAIN (sore throat) outcome was unknown.            No concomitant medication use was provided by the reporter.  Treatment of events were reported with camphor, menthol and eucalyptus oil (Vicks Vapor Rub) on an unknown start date.
I broke out in hives all over my body and have been taking Benadryl. My face, eyes, hands, feet, and genital area became swollen. I ended up at the hospital's ER when my throat became swollen because I could not breathe and it has happen twice. I was given steroids, Benadryl, and Pepsin. The Benadryl did nothing for my hives so I switched to Zyrtec (helped with the hives but not completely - approximately 90%).  I am still taking the Zyrtec and was admitted to the ER a week in a half ago. My face and jaw area were swollen recently but I didn't go to the hospital's ER.
Information has been received from a lawyer regarding a case in litigation concerning a male patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended and/or prescribed the ZOSTAVAX vaccine to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. In August 2016, a pharmacist at a pharmacy administered the ZOSTAVAX vaccine to the patient (lot number, dosage and route of administration not provided). On an unknown date in 2017, the patient was treated by a physician for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization (dates unknown), physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity, and other losses and damages. The outcome of the events was considered to be not recovered. Additional information has been requested.
Pt had cough and shortness of breath at 10 PM. Runny nose at 4 PM and Temperature at 5 PM. Stuffiness by 8 PM. After 12 hrs all symptoms lessened.